Cencora, Inc.

  • Market Cap: Large Cap
  • Industry: Retailing
  • ISIN: US03073E1055
USD
337.63
2.32 (0.69%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryCompany CV
About Cencora, Inc. stock-summary
stock-summary
Cencora, Inc.
Retailing
AmerisourceBergen Corporation is a pharmaceutical sourcing and distribution services company. The Company's segments include Pharmaceutical Distribution and Other. The Company provides services to healthcare providers, and pharmaceutical and biotech manufacturers. As of June 30, 2016, the Pharmaceutical Distribution segment consists of two operating segments, including the operations of AmerisourceBergen Drug Corporation (ABDC) and AmerisourceBergen Specialty Group (ABSG), which distributes specialty drugs to their customers. Servicing healthcare providers in the pharmaceutical supply channel, the Pharmaceutical Distribution segment's operations provide drug distribution and related services. The Other segment consists of the operations of various segments, including the AmerisourceBergen Consulting Services (ABCS), the World Courier Group, Inc. and the MWI Veterinary Supply, Inc. ABSG operates distribution facilities that focus primarily on complex disease treatment regimens.
Company Coordinates stock-summary
Company Details
1300 Morris Dr , CHESTERBROOK PA : 19087-5594
stock-summary
Tel: 1 610 7277000
stock-summary
stock-summary
Registrar Details
stock-recommendation Shareholding
Shareholding Snapshotstock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Domestic Funds

Domestic Funds

Held in 182 Schemes (40.25%)

Foreign Institutions

Held by 424 Foreign Institutions (21.96%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summary Board of Directorsstock-summary
Management
Designation
Mr. Steven Collis
Chairman of the Board, President, Chief Executive Officer
Dr. Jane Henney
Lead Independent Director
Ms. Ornella Barra
Director
Mr. D. Mark Durcan
Independent Director
Mr. Richard Gochnauer
Independent Director
Mr. Lon Greenberg
Independent Director
stock-recommendation Stock DNA
Revenue and Profits:
Net Sales:
80,664 Million
(Quarterly Results - Jun 2025)
Net Profit:
690 Million
stock-summary
Industry

Retailing

stock-summary
Market cap

USD 82,362 Million (Large Cap)

stock-summary
P/E

44.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

27.26%

stock-summary
Debt Equity

3.01

stock-summary
Return on Equity

103.76%

stock-summary
Price to Book

41.59